We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-3.09%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.47B
AUM Growth
-$81M
Cap. Flow
-$152K
Cap. Flow %
-0.01%
Top 10 Hldgs %
30.16%
Holding
216
New
9
Increased
67
Reduced
76
Closed
10

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$12.1M
2
PPLI
People Inc
PPLI
+$3.64M
3
AZO icon
AutoZone
AZO
+$2.79M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$1.09M
5
DIS icon
Walt Disney
DIS
+$860K

Top Sells

Rank Stock Value
1
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$9.51M
2
BC icon
Brunswick
BC
+$3.76M
3
FDX icon
FedEx
FDX
+$3.74M
4
MSFT icon
Microsoft
MSFT
+$1.88M
5
DVN icon
Devon Energy
DVN
+$864K

Sector Composition

Rank Sector Weight
1 Technology 29.23%
2 Healthcare 15.02%
3 Industrials 12.32%
4 Financials 11.75%
5 Consumer Staples 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
26
Weyerhaeuser
WY
$17.7B
$23M 1.56%
606,375
+1,460
+0.2% +$57.9K
DIS icon
27
Walt Disney
DIS
$172B
$22.6M 1.53%
164,777
+5,949
+4% +$860K
CVX icon
28
Chevron
CVX
$374B
$21.7M 1.47%
133,475
-109
-0.1% -$15.6K
MTB icon
29
M&T Bank
MTB
$36.6B
$20.8M 1.41%
122,420
-442
-0.4% -$77.9K
UL icon
30
Unilever
UL
$144B
$20.3M 1.37%
395,270
+4,911
+1% +$273K
REGN icon
31
Regeneron Pharmaceuticals
REGN
$72.9B
$20.1M 1.36%
28,774
+977
+4% +$618K
PG icon
32
Procter & Gamble
PG
$347B
$19M 1.29%
124,067
-1,320
-1% -$207K
AAPL icon
33
Apple
AAPL
$4.99T
$18.9M 1.28%
108,124
+340
+0.3% +$57.2K
JNJ icon
34
Johnson & Johnson
JNJ
$643B
$18.9M 1.28%
106,538
-1,103
-1% -$188K
DVN icon
35
Devon Energy
DVN
$49.2B
$18.6M 1.27%
315,264
-15,965
-5% -$864K
SNY icon
36
Sanofi
SNY
$109B
$17.4M 1.18%
338,090
+3,100
+0.9% +$160K
HXL icon
37
Hexcel
HXL
$8.3B
$17.3M 1.17%
290,947
+3,310
+1% +$182K
WLY icon
38
John Wiley & Sons Class A
WLY
$2.76B
$16.8M 1.14%
316,532
+2,664
+0.8% +$140K
ZBH icon
39
Zimmer Biomet
ZBH
$18.5B
$16.3M 1.11%
127,434
-4,014
-3% -$484K
CTSH icon
40
Cognizant
CTSH
$23.8B
$16.3M 1.1%
181,248
+770
+0.4% +$67.7K
PPG icon
41
PPG Industries
PPG
$26.5B
$15.7M 1.07%
119,760
+1,661
+1% +$241K
GILD icon
42
Gilead Sciences
GILD
$167B
$15M 1.02%
251,842
+8,546
+4% +$546K
GLW icon
43
Corning
GLW
$108B
$13.3M 0.9%
360,804
-565
-0.2% -$22K
XOM icon
44
ExxonMobil
XOM
$634B
$13.3M 0.9%
161,036
+1,826
+1% +$142K
FDX icon
45
FedEx
FDX
$74B
$12.6M 0.85%
54,304
-15,920
-23% -$3.74M
TMO icon
46
Thermo Fisher Scientific
TMO
$214B
$12.5M 0.85%
21,216
-811
-4% -$466K
SHEL icon
47
Shell
SHEL
$238B
$12.5M 0.85%
+227,559
New +$12.1M
NVS icon
48
Novartis
NVS
$304B
$11.8M 0.8%
134,065
+4,480
+3% +$388K
BRK.A icon
49
Berkshire Hathaway Class A
BRK.A
$1.1T
$10.6M 0.72%
20
-1
-5% -$485K
BC icon
50
Brunswick
BC
$5.33B
$10.3M 0.7%
127,793
-40,810
-24% -$3.76M

Similar funds

Grandfield & Dodd's Q1 2022 Portfolio in Review

As of Q1 2022, Grandfield & Dodd held 216 positions worth $1.47B, down 5.2% from $1.55B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q1 2022 filing shows 9 new, 67 increased, 76 reduced and 10 closed positions. Its largest new stake was Shell: 227,559 shares worth $12.5M. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $9.51M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q1 2022 buy was Shell: 227,559 shares worth $12.5M.
  • Grandfield & Dodd added most to People Inc in Q1 2022, an estimated $3.64M increase.
  • Grandfield & Dodd's biggest Q1 2022 reduction was Brunswick, cutting an estimated $3.76M.
  • Grandfield & Dodd fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $9.51M.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.47B portfolio in Q1 2022.
  • Grandfield & Dodd opened 9 new positions and closed 10 in Q1 2022.
  • Grandfield & Dodd's portfolio value fell 5.2% quarter-over-quarter to $1.47B.

Based on Grandfield & Dodd's 13F filing for Q1 2022, filed 19 Apr 2022.